Natasha B Leighl

Natasha B Leighl, BSc, MSc, MD

  • Lung cancer therapy including novel compounds and early phase trials
  • Breast cancer therapeutics including novel compounds and early phase trials
  • Health services research
  • Economics of lung cancer therapy
  • Treatment decision-making in advanced cancer, including development of patient decision aids
  • Patient-physician communication
Clin Lung Cancer. 2017 Jun 21;:
Dudani S, Zhu X, Yokom DW, Yamada A, Ho C, Pantarotto JR, Leighl NB, Zhang T, Wheatley-Price P
Oncotarget. 2017 Jun 28;:
Leighl NB, Tsao MS, Liu G, Tu D, Ho C, Shepherd FA, Murray N, Goffin JR, Nicholas G, Sakashita S, Chen Z, Kim L, Powers J, Seymour L, Goss G, Bradbury PA
Nat Genet. 2017 Jun 12;:
McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, Caporaso NE, Johansson M, Xiao X, Li Y, Byun J, Dunning A, Pooley KA, Qian DC, Ji X, Liu G, Timofeeva MN, Bojesen SE, Wu X, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS...
J Thorac Oncol. 2017 May 27;:
Soo RA, Stone EC, Cummings KM, Jett JR, Field JK, Groen HJ, Mulshine JL, Yatabe Y, Bubendorf L, Dacic S, Rami-Porta R, Detterbeck FC, Lim E, Asamura H, Donington J, Wakelee HA, Wu YL, Higgins K, Senan S, Solomon B, Kim DW, Johnson M, Yang JC, Sequist...
Lung Cancer. 2017 Jul;109:78-88
Wakeam E, Acuna SA, Leighl NB, Giuliani ME, Finlayson SRG, Varghese TK, Darling GE
Lung Cancer. 2017 Jul;109:137-144
O'Kane GM, Bradbury PA, Feld R, Leighl NB, Liu G, Pisters KM, Kamel-Reid S, Tsao MS, Shepherd FA
Lung Cancer. 2017 Jul;109:117-123
Wakeam E, Varghese TK, Leighl NB, Giuliani M, Finlayson SRG, Darling GE
J Clin Oncol. 2017 Jun 02;:JCO2016716894
Cheng S, McDonald EJ, Cheung MC, Arciero VS, Qureshi M, Jiang D, Ezeife D, Sabharwal M, Chambers A, Han D, Leighl N, Sabarre KA, Chan KKW

Pages


Associate Professor, Department of Medicine, University of Toronto
President, Lung Cancer Canada
Chair, Working Group on Economic Analysis, National Cancer Institute of Canada Clinical Trials Group​